医学
冠状动脉疾病
内科学
心脏病学
逻辑回归
阻塞性睡眠呼吸暂停
经皮冠状动脉介入治疗
睡眠呼吸暂停
睡眠研究
呼吸暂停
多导睡眠图
心肌梗塞
作者
Hehe Zhang,Бо Лю,Yue Jiao,Jing Zhang,Naima Covassin,Mu Wang,Lin Yun,Jiang Xie
标识
DOI:10.1007/s11325-024-03008-1
摘要
Abstract Purpose Sleep apnea-specific hypoxic burden (SASHB) is a polysomnographic metric that comprehensively measures the degree of nocturnal desaturation caused by obstructive sleep apnea. This research was conducted to elucidate the relationship between SASHB and coronary artery disease (CAD) severity. Methods We carried out a prospective study of hospitalized patients with CAD of unstable angina who were expected to undergo invasive coronary angiography at Beijing Anzhen Hospital from February to September 2023. SASHB values were calculated using a self-programmed C + + program. Multivariable logistic regression analysis was applied to identify the association between SASHB and the prevalence of severe CAD, documented by the Gensini Score, and the SYNTAX (Synergy between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score. Results This study enrolled 137 patients with a median age of 59 years, 96 (70.1%) of whom were male. A total of 125 (91.2%) patients had coronary stenosis of ≥ 50% in at least one location. Patients with a high SASHB of ≥ 18% min/h had a significantly higher Gensini Score (32.0 vs. 18.5, P = 0.002) and SYNTAX Score (14.0 vs. 7.0, P = 0.002) than those with a low SASHB. After adjusting for multiple covariates, a high SASHB was significantly associated with the prevalence of severe CAD, determined by a Gensini Score ≥ 21 (OR 2.67, P = 0.008) or a SYNTAX Score > 22 (OR 4.03, P = 0.016). Conclusion Our findings revealed a robust and independent association between SASHB and CAD severity in patients with unstable angina, highlighting the potential value of SASHB as a predictor of risk and a target for interventions aimed at preventing cardiovascular diseases. Trial registration Chinese Clinical Trial Registry No. ChiCTR2300067991 on February 2, 2023.
科研通智能强力驱动
Strongly Powered by AbleSci AI